[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:metabolic-dysfunction-associated-steatohepatitis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":21,"states":22},"Metabolic Dysfunction Associated Steatohepatitis",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06632444","LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH\u002FMASH Who Have Moderate or Advanced Liver Fibrosis",[11],"Phase 3","RECRUITING","2026-08-26T02:18:52.966503Z","2026-05-05T02:43:29.514193Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06632457","LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH\u002FMASH Who Have Cirrhosis",[11],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:27.796433Z",[],[]]